Erbguth F, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the «sausage poison». Neurology. 1999;53:1850–3, 10.
Dover N, Barash JR, Hill KK, Xie G, Arnon SS. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis. 2014;209:192–202, 15.
Walker TJ, Dayan. SH. Comparison and overview of currently available neurotoxins. J Clin Aesthet Dermatol. 2014;7: 31–9.
Naumann M, Jancovic J. Safety of botulinum toxin type A: A systematic review and metaanalysis. Curr Med Res Opin. 2004;20:981–90.
DOI: 10.1185/030079904125003962
Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 1980;17:21–5.
DOI: 10.3928/0191-3913-19800101-06
Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21.
Ibarra-Hurtado TR, Nun˜ o-Guzmán CM, Echeagaray-Herrera JE, Robles-Vélez E, González-Jaime JJ. Use of botulinum toxin type A before abdominal wall hernia reconstruction. World J
Hanchanale VS, Rao AR, Martin FL, Matanhelia SS. The unusual history and the urological applications of botulinum neurotoxin. Urol Int. 2010;85:125–30.
DOI: 10.1159/000317517
Gon˜ i-Moreno I. El neumoperitoneo preoperatorio en la cirugía de las grandes hernias y eventraciones. El Día Medico. 1947;19:29.
Jacobsen W, Petty P, Bite U, Johnson C. Massive abdominal-wall hernia reconstruction with expanded external/internal oblique and transversalis musculo-fascia. Plastic Reconstr Surg. 1997;100:326–35.
DOI: 10.1097/00006534-199708000-00007